Journal
JOURNAL OF VIROLOGY
Volume 87, Issue 24, Pages 13853-13867Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.02159-13
Keywords
-
Categories
Funding
- British Skin Foundation
- BBSRC DTG studentship and research development fellowship
- Cancer Research United Kingdom
- Yorkshire Cancer Research
- College of Pharmacy, University of Basrah, Ministry of Higher Education and Scientific Research Iraq, scholarship
Ask authors/readers for more resources
Merkel cell carcinoma (MCC) is a highly aggressive nonmelanoma skin cancer arising from epidermal mechanoreceptor Merkel cells. In 2008, a novel human polyomavirus, Merkel cell polyomavirus (MCPyV), was identified and is strongly implicated in MCC pathogenesis. Currently, little is known regarding the virus-host cell interactions which support virus replication and virus-induced mechanisms in cellular transformation and metastasis. Here we identify a new function of MCPyV small T antigen (ST) as an inhibitor of NF-kappa B-mediated transcription. This effect is due to an interaction between MCPyV ST and the NF-kappa B essential modulator (NEMO) adaptor protein. MCPyV ST expression inhibits I kappa B kinase alpha (IKK alpha)/IKK beta-mediated I kappa B phosphorylation, which limits translocation of the NF-kappa B heterodimer to the nucleus. Regulation of this process involves a previously undescribed interaction between MCPyV ST and the cellular phosphatase subunits, protein phosphatase 4C (PP4C) and/or protein phosphatase 2A (PP2A) A beta, but not PP2A A alpha. Together, these results highlight a novel function of MCPyV ST to subvert the innate immune response, allowing establishment of early or persistent infection within the host cell.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available